Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 1
1996 1
1997 1
1998 2
1999 1
2000 3
2001 3
2002 3
2003 6
2004 8
2005 8
2006 7
2007 12
2008 8
2009 9
2010 19
2011 28
2012 27
2013 33
2014 36
2015 35
2016 39
2017 47
2018 33
2019 36
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

373 results
Results by year
Filters applied: . Clear all
Page 1
Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib.
Karkera JD, Cardona GM, Bell K, Gaffney D, Portale JC, Santiago-Walker A, Moy CH, King P, Sharp M, Bahleda R, Luo FR, Alvarez JD, Lorenzi MV, Platero SJ. Karkera JD, et al. Mol Cancer Ther. 2017 Aug;16(8):1717-1726. doi: 10.1158/1535-7163.MCT-16-0518. Epub 2017 Apr 17. Mol Cancer Ther. 2017. PMID: 28416604 Free article.
Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.
Nishina T, Takahashi S, Iwasawa R, Noguchi H, Aoki M, Doi T. Nishina T, et al. Invest New Drugs. 2018 Jun;36(3):424-434. doi: 10.1007/s10637-017-0514-4. Epub 2017 Sep 30. Invest New Drugs. 2018. PMID: 28965185 Clinical Trial.
Targeting FGFR pathway in breast cancer.
Perez-Garcia J, Muñoz-Couselo E, Soberino J, Racca F, Cortes J. Perez-Garcia J, et al. Breast. 2018 Feb;37:126-133. doi: 10.1016/j.breast.2017.10.014. Epub 2017 Nov 20. Breast. 2018. PMID: 29156384 Review.
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Morales-Barrera R, Suárez C, de Castro AM, Racca F, Valverde C, Maldonado X, Bastaros JM, Morote J, Carles J. Morales-Barrera R, et al. Cancer Treat Rev. 2016 Nov;50:208-216. doi: 10.1016/j.ctrv.2016.09.018. Epub 2016 Oct 1. Cancer Treat Rev. 2016. PMID: 27743530 Review.
Future applications of FGF/FGFR inhibitors in cancer.
Ghedini GC, Ronca R, Presta M, Giacomini A. Ghedini GC, et al. Expert Rev Anticancer Ther. 2018 Sep;18(9):861-872. doi: 10.1080/14737140.2018.1491795. Epub 2018 Jul 2. Expert Rev Anticancer Ther. 2018. PMID: 29936878 Review.
373 results
Jump to page
Feedback